EUVIMEDEUVIMED entdecken
Crossref

Detection of the Uveal Melanoma-Associated Mutation GNAQ Q209P from Liquid Biopsy Using CRISPR/Cas12a Technology

Carmen Escalona-Noguero, Hernán Alarcón-Iniesta, María López-Valls, Luis Paul Del Carpio, Josep M Piulats, Álvaro Somoza iD, Begoña Sot iD

Analytical Chemistry · 2023

DOI: 10.1021/acs.analchem.3c03460 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2023. Verfasst von Carmen Escalona-Noguero und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fundación IMDEA Nanociencia, Campus Universitario de Cantoblanco, Madrid 28049, Spain. Hauptthemen laut MEDLINE: GTP-Binding Protein alpha Subunits, Gq-G11, GTP-Binding Protein alpha Subunits. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Comunidad de Madrid, Ministerio de Ciencia e Innovaci?n, Fundaci?n Cient?fica Asociaci?n Espa?ola Contra el C?ncer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GTP-Binding Protein alpha Subunits, Gq-G11GTP-Binding Protein alpha SubunitsUveal NeoplasmsMutationHumansCRISPR-Cas SystemsMelanomaUveal Melanoma

Substanzen

GTP-Binding Protein alpha Subunits, Gq-G11GTP-Binding Protein alpha SubunitsGNAQ protein, human

Autor:innen und Institutionen

  • Fundación IMDEA Nanociencia, Campus Universitario de Cantoblanco, Madrid 28049, Spain.
  • Medical Oncology Department, Institut Català d'Oncologia─ICO, L'Hospitalet de Llobregat, IDIBELL, Barcelona 08908, Spain.
  • Cancer ImmunoTherapy (CIT) Group-iPROCURE, Bellvitge Biomedical Research Institute IDIBELL-OncoBell, L'Hospitalet de Llobregat, Barcelona 08908, Spain.
  • Unidad Asociada de Nanobiotecnología (CNB-CSIC e IMDEA Nanociencia), Madrid 28049, Spain.
  • Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Unidad de Innovación Biomédica, Complutense 40, Madrid 28040, Spain.
  • Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJ UAM), Madrid 28040, Spain.

ORCID-Profile: Álvaro Somoza, Begoña Sot

Förderung

  • Comunidad de Madrid
  • Ministerio de Ciencia e Innovaci?n
  • Fundaci?n Cient?fica Asociaci?n Espa?ola Contra el C?ncer
  • Sociedad Espa?ola de Oncolog?a M?dica

Zitieren

APA

Escalona-Noguero, C., Alarcón-Iniesta, H., López-Valls, M., Del Carpio, L. P., Piulats, J. M., Somoza, Á., & Sot, B. (2023). Detection of the Uveal Melanoma-Associated Mutation GNAQ Q209P from Liquid Biopsy Using CRISPR/Cas12a Technology. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.3c03460

Vancouver

Escalona-Noguero C, Alarcón-Iniesta H, López-Valls M, Del Carpio LP, Piulats JM, Somoza Á, et al. Detection of the Uveal Melanoma-Associated Mutation GNAQ Q209P from Liquid Biopsy Using CRISPR/Cas12a Technology. Analytical Chemistry. 2023. doi:10.1021/acs.analchem.3c03460

BibTeX
@article{EscalonaNoguero2023,
  author = {Escalona-Noguero, Carmen and Alarcón-Iniesta, Hernán and López-Valls, María and Del Carpio, Luis Paul and Piulats, Josep M and Somoza, Álvaro and Sot, Begoña},
  title = {Detection of the Uveal Melanoma-Associated Mutation GNAQ Q209P from Liquid Biopsy Using CRISPR/Cas12a Technology},
  journal = {Analytical Chemistry},
  year = {2023},
  doi = {10.1021/acs.analchem.3c03460}
}
Kostenlos starten →